Aoyama Medical Clinic, Kobe, Japan.
Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan,
Digestion. 2021;102(1):12-17. doi: 10.1159/000511481. Epub 2020 Nov 25.
While the number of inflammatory bowel disease (IBD) patients has been steadily increasing, a lot of effective treatments have become available, including biological drugs. However, there still exists no effective treatment universally for all types of IBD patients. We have continuously discussed "Total Care" for IBD patients in the 3 consecutive annual meetings of the Japanese Gastroenterological Association from the 14th meeting to the 16th meeting in 2018-2020.
In the 14th meeting, we summarized cross-sectional issues under the title "From Total Care to Microbiota" as for their subthemes. In the 15th meeting, under the title of "Consensus and Pitfalls in Special Situations," we discussed the thiopurine treatment for the patients in their childhood or pregnancy and lactation period as well as the cytapheresis treatment for elderly patients. In the 16th meeting, under the title "Future Issues in Special Situations: Including Disease Burden," we discussed about the issues in childhood-onset IBD, including transitional care and the new option of combination of treatments in their adulthood and their disease burdens. Key Messages: "Total Care" for IBD patients should be considered from a broad perspective with shared decision-making. It is imperative to involve medical staff members for careful handling of a wide range of disease burdens.
尽管炎症性肠病 (IBD) 患者的数量一直在稳步增加，并且有许多有效的治疗方法可供选择，包括生物药物。然而，目前还没有针对所有类型 IBD 患者的通用有效治疗方法。我们在 2018 年至 2020 年的日本胃肠病学会第 14 次至第 16 次年度会议上连续讨论了 IBD 患者的“全面护理”。
在第 14 次会议上，我们总结了以“从全面护理到微生物组”为标题的跨学科问题，作为其子主题。在第 15 次会议上，我们以“特殊情况下的共识和陷阱”为标题，讨论了儿童期或妊娠和哺乳期患者的硫嘌呤治疗以及老年患者的细胞分离治疗。在第 16 次会议上，我们以“特殊情况下的未来问题：包括疾病负担”为标题，讨论了儿童发病 IBD 的问题，包括过渡护理和成年期联合治疗的新选择及其疾病负担。关键信息：应从广泛的角度考虑 IBD 患者的“全面护理”，并进行共同决策。必须让医务人员参与进来，以认真处理各种疾病负担。
